|
Tabengwa, E M; Benza, R L; Grenett, H E et al. (2000) Hypertriglyceridemic VLDL downregulates tissue plasminogen activator gene transcription through cis-repressive region(s) in the tissue plasminogen activator promoter in cultured human endothelial cells. Arterioscler Thromb Vasc Biol 20:1675-81
|
|
Benza, R L; Grenett, H E; Bourge, R C et al. (1998) Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease. Circulation 98:2248-54
|
|
Grenett, H E; Benza, R L; Fless, G M et al. (1998) Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells. Arterioscler Thromb Vasc Biol 18:1803-9
|
|
Li, X N; Grenett, H E; Benza, R L et al. (1997) Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells. Arterioscler Thromb Vasc Biol 17:3215-23
|
|
Li, X N; Koons, J C; Benza, R L et al. (1996) Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysis. Biochemistry 35:6080-8
|
